Ann: Australian Distribution Partner Receives MC Import Licence, page-74

I'm a little confused by today's announcements, welcome the insight of those that have been around longer than I:

MMJ PhytoTech Limited (ASX: MMJ) (“MMJ” or “the Company”) is pleased to advise that the Company’s Australian distribution partner, HL Pharma Pty Ltd (“HL Pharma”), has received approval for a medicinal cannabis importation licence from the Department of Health.

This is a significant development for MMJ as it enables the Company to target direct supply to Australian pharmacies through its strategic partnership with Melbourne-based HL Pharma. With its extensive Australian distribution networks, HL Pharma provides the requisite framework to facilitate the importation of Satipharm AG’s (“Satipharm”) CBD capsules to approved customers


So the effect of the announcement is that it allows HL Pharma to purchase its product from Satipharm AG.

But, the most recent announcement says that Satipharm AG has been sold to Harvest One.

How does this announcement help MMJ once fhe sale of Satipharm is settled?